Article
Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia.
Leukemia - 1 Nov 2020
Kloos Arnold, Mintzas Konstantinos, Winckler Lina, Gabdoulline Razif, Alwie Yasmine, Jyotsana Nidhi, Kattre Nadine, Schottmann Renate, Scherr Michaela, Gupta Charu, Adams Felix F, Schwarzer Adrian, Heckl Dirk, Schambach Axel, Imren Suzan, Humphries R Keith, Ganser Arnold, Thol Felicitas, Heuser Michael
Abstract excerpt
To establish novel and effective treatment combinations for chronic myelomonocytic leukemia (CMML) preclinically, we hypothesized that supplementation of CMML cells with the human oncogene Meningioma 1 (MN1) promotes expansion and serial transplantability in mice, while maintaining the functional dependencies of these cells on their original genetic profile. Using lentiviral expression of MN1 for oncogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
